Translational Biology in Medicine

Dr Monty Montano is currently on the faculty at Harvard Medical School in the Department of Medicine. Dr Montano's laboratory is broadly interested in HIV infection, muscle wasting, fibrosis, and aging bioscience. Dr Montano is also the founder and president of MyoSyntax, a life sciences company focused on identifyingpersonalized supplements that optimize gains in and reduce losses of muscle mass.

Dedication
List of figures
Abbreviations
About the author
1: Introduction and overview of chapter contents

Abstract


2: Model systems

Abstract
2.1 Introduction
2.2 Immortalized cell lines
2.3 Primary cells obtained from the host
2.4 Animal models
2.5 Stem cells: adult and induced pluripotent


3: Blood biomarkers: overview of existing serum test strategies for disease severity, risk for progression, therapeutic benchmark targets

Abstract
3.1 Introduction
3.2 Early definition of biomarkers
3.3 Initial biomarker discovery
3.4 Translation into animal models
3.5 Translation into small human populations
3.6 Application to larger, more generalizable populations
3.7 Biomarker measurement considerations


4: Genetic and genomic profiling

Abstract
4.1 Introduction
4.2 Theories of heritability of disease risk and severity
4.3 Gene expression signatures
4.4 Examples of gene expression signatures


5: Translational models, methods and concepts in studies of aging and longevity

Abstract
5.1 Introduction
5.2 Theories of aging
5.3 The here and now: the world is aging
5.4 Telomere length/activity in aging
5.5 Stem cell aging
5.6 Aging and muscle tissue regeneration
5.7 Immune aging and immunosenescence
5.8 The insulin/IGF1 signaling axis in aging
5.9 Branched-chain amino acids (BCAA) and aging
5.10 Measurement of lifespan modulators
5.11 Factors influencing aging


6: Translational models, methods and concepts in studies of muscle tissue repair

Abstract
6.1 Introduction
6.2 Muscle maintenance and regeneration
6.3 The role of satellite cell activity in aging and decline in muscle function
6.4 Muscle growth regulatory pathways
6.5 Sarcopenia and muscle maintenance
6.6 Functional limitations and therapeutic drug design
6.7 The TGFb1 axis
6.8 Inflammatory stress and muscle
6.9 Cachexia and muscle homeostasis
6.10 Anabolic effects of testosterone treatment
6.11 Use of high-throughput technologies with muscle to promote musculoskeletal growth


7: Translational models, methods and concepts in studies of acute and chronic infection

Abstract
7.1 Introduction
7.2 From HIV origins to the modern era
7.3 HIV infection and aging
7.4 HIV-1 infection and transmission
7.5 Infection and innate host response
7.6 HIV and adaptive host response
7.7 HIV-1 comorbid conditions
7.8 HIV and drugs
7.9 Infection-associated inflammation and aging promote fibrosis
7.10 Viral eradication studies


8: Bioethical considerations and IRB challenges in translational biology study design and bioethical considerations in biomedical research

Abstract
8.1 Institutional review boards
8.2 Institutional animal care and use committee (IACUC)
8.3 Big Data and the online privacy of health information


9: Concluding remarks and the future of personalized medicine

Abstract
9.1 Introduction
9.2 Personalized medicine and aging
9.3 Personalized medicine and muscle maintenance
9.4 Personalized medicine and infectious diseases: HIV


References
Index